Impaired IGF1-GH axis and new therapeutic options in Alström Syndrome patients: A case series

Cases Journal

Volumn 2, Issue 1, 2009, Pages

  Mihai, Cristina Maria ^a   Catrinoiu, Doina ^a   Toringhibel, Marius ^a   Stoicescu, Ramona Mihaela ^a   Ticuta, Negreanu Pirjol ^a   Anca, Hancu ^a  

^a OVIDIUS UNIVERSITY   (Romania)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; INSULIN; RECOMBINANT GROWTH HORMONE; SOMATOMEDIN C;

ADOLESCENT; ADULT; ALSTROM SYNDROME; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CARDIOMYOPATHY; CASE REPORT; EMPTY SELLA SYNDROME; FEMALE; GROWTH HORMONE DEFICIENCY; HUMAN; HYPOGLYCEMIA; INSULIN RESISTANCE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PROVOCATION TEST; RARE DISEASE; TREATMENT DURATION;

EID: 77953366732     PISSN: 17571626     EISSN: None     Source Type: Journal    
DOI: 10.1186/1757-1626-2-19     Document Type: Article

References (41)

1. Alström CH, Hallgren B, Nilsson LB, Asander H: Retinal degeneration combined with obesity, diabetes mellitus and neurogenous deafness. Acta Psychiatr Neurol Scand 1959, 34(Suppl 129):1-35.
2. Hearn T, Spalluto C, Phillips VJ, Renforth GL, Copin N, Hanley NA, Wilson DI: Subcellular localization of ALMS1 supports involvement of centrosome and basal body dysfunction in the pathogenesis of obesity, insulin resistance, and type 2 diabetes. Diabetes 2005, 54(5):1581-1587 (Pubitemid 40586693)
3. Hildebrandt F, Otto E: Cilia and centrosomes: A unifying pathogenic concept for cystic kidney disease? Nat Rev Genet 2005, 6:928-940. (Pubitemid 41778699)
4. Davenport JR, Yoder BK: An incredible decade for the primary cilium: A look at a once-forgotten organelle. Am J Physiol 2005, 289:F1159-F1169.
5. Badano JL, Mitsuma N, Beales PL, Katsanis N: The ciliopathies: An emerging class of human genetic disorders. Annu Rev Genomics Hum Genet 2006, 7:125-148. (Pubitemid 44627925)
6. Shiratori H, Hamada H: The left-right axis in the mouse: from origin to morphology. Development 2006, 133:2095-2104. (Pubitemid 43986120)
7. Ibañez-Tallon Inés, Heintz Nathaniel, Omran Heymut: To beat or not to beat: roles of cilia in development and disease. Human Molecular Genetics 2003, 12(1):R27-R35. (Pubitemid 36442951)
8. Wheatley DN, Wang AM, Strugnell GE: Expression of primary cilia in mammalian cells. Cell Biol Int 1996, 20:73-81.
9. Eley L, Yates LM, Goodship JA: Cilia and disease. Curr Opin Genet Dev 2005, 15:308-314.
10. Pan J, Wang Q, Snell WJ: Cilium-generated signaling and cilia-related disorders. Lab Invest 2005, 85:452-463.
11. Singla V, Reiter JF: The primary cilium as the cell's antenna: Signaling at a sensory organelle. Science 2006, 313:629-633. (Pubitemid 44201133)
12. Marshall WF, Nonaka S: Cilia: Tuning in to the cell's antenna. Curr Biol 2006, 16:R604-R61.
13. Eggenschwiler JT, Anderson KV: Cilia and developmental signaling. Annu Rev Cell Dev Biol 2007, 23:345-373.
14. Praetorius HA, Spring KR: Bending the MDCK cell primary cilium increases intracellular calcium. J Membr Biol 2001, 184:71-79.
15. Nauli SM, Alenghat FJ, Luo Y, Williams E, Vassilev P, Li X, Elia AE, Lu W, Brown EM, Quinn SJ, Ingber DE, Zhou J: Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells. Nat Genet 2003, 33:129-137. (Pubitemid 36177063)
16. Fliegauf M, Benzing T, Omran H: When cilia go bad: Cilia defects and ciliopathies. Nat Rev Mol Cell Biol 2007, 8:880-893. (Pubitemid 47622564)
17. Andersen JS, Wilkinson CJ, Mayor T, Mortensen P, Nigg EA, Mann M: Proteomic characterization of the human centrosome by protein correlation profiling. Nature 2003, 426:570-574. (Pubitemid 37522644)
18. Ansley SJ, Badano JL, Blacque OE, Hill J, Hoskins BE, Leitch CC, Kim JC, Ross AJ, Eichers ER, Teslovich TM, Mah AK, Johnsen RC, Cavender JC, Lewis RA, Leroux MR, Beales PL, Katsanis N: Basal body dysfunction is a likely cause of pleiotropic Bardet-Biedl syndrome. Nature 2003, 425:628-633. (Pubitemid 37280147)
19. Kyttala M, Tallila J, Salonen R, Kopra O, Kohlschmidt N, Paavola-Sakki P, Peltonen L, Kestila M: MKS1, encoding a component of the flagellar apparatus basal body proteome, is mutated in Meckel syndrome. Nat Genet 2006, 38:155-157. (Pubitemid 43177228)
20. Romio L, Fry AM, Winyard PJ, Malcolm S, Woolf AS, Feather SA: OFD1 is a centrosomal/basal body protein expressed during mesenchymal-epithelial transition in human nephrogenesis. J Am Soc Nephrol 2004, 15:2556-2568. (Pubitemid 41103362)
21. Händel M, Schulz S, Stanarius A, Schreff M, Erdtmann-Vourliotis M, Schmidt H, Wolf G, Höllt V: Selective targeting of somatostatin receptor 3 to neuronal cilia. Neuroscience 1999, 89:909-926.
22. Hamon M, Doucet E, Lefèvre K, Miquel MC, Lanfumey L, Insausti R, Frechilla D, Del Rio J, Vergé D: Antibodies and antisense oligonucleotide for probing the distribution and putative functions of central 5-HT6 receptors. Neuropsychopharmacology 1999, 21:68S-76S. (Pubitemid 29396473)
23. Brailov I, Bancila M, Brisorgueil MJ, Miquel MC, Hamon M, Vergé D: Localization of 5-HT(6) receptors at the plasma membrane of neuronal cilia in the rat brain. Brain Res 2000, 872:271-275. (Pubitemid 30618919)
24. Arsov T, Silva DG, O'Bryan MK, Sainsbury A, Lee NJ, Kennedy C, Manji SS, Nelms K, Liu C, Vinuesa CG, de Kretser DM, Goodnow CC, Petrovsky N: Fat Aussie - A New Alstrom Syndrome Mouse Showing A Critical Role for ALMS1 in Obesity, Diabetes, and Spermatogenesis. Mol Endocrinol 2006. (Pubitemid 43967568)
25. Boschetti M, Maffei P, Orsi I, Piredda S, Foppiani L, Marshall JD, Paisey R, Beck S, Munno V, Minuto F, Barreca A, Sicolo N: The IGF System in Alström Syndrome and Obese Patients. J Endocrin Investigation 2003, 26(Suppl to No.6):74.
26. Marshall JD, Hinman EG, Collin GB, Beck S, Cerqueira R, Maffei P, Milan G, Zhang W, Wilson DI, Hearn T, Tavares P, Vettor R, Veronese C, Martin M, So WV, Nishina PM, Naggert JK: Spectrum of ALMS1 variants and evaluation of genotype-phenotype correlations in Alstrom syndrome. Hum Mutat 2007, 28(11):1114-1123 (Pubitemid 350036916)
27. Marshall JD, Bronson RT, Collin GB, Nordstrom AD, Maffei P, Paisey RB, Carey C, Macdermott S, Russell-Eggitt I, Shea SE, Davis J, Beck S, Shatirishvili G, Mihai CM, Hoeltzenbein M, Pozzan GB, Hopkinson I, Sicolo N, Naggert JK, Nishina PM: New Alstrom syndrome phenotypes based on the evaluation of 182 cases. Arch Intern Med 2005, 165(6):675-683 (Pubitemid 40393151)
28. Jones SL: An audit of the insulin tolerance test in adult subjects in an acute investigation unit over one year. Clin Endocrinol 1994, 41:123-128.
29. Hoeck HC: Test of growth hormone secretion in adults: poor reproducibility of the insulin tolerance test. Eur J Endocrinol 1995, 133:305-312.
30. Vestergaard P: Reproducibility of growth hormone and cortisol responses to the insulin tolerance test and the short ACTH test in normal adults. Horm Metab Res 1997, 29:106-110.
31. Soliman AT, Rajab A, AlSalmi I, Asfour MG: Empty sella, impaired testosterone secretion, and defective hypothalamic-pituitary growth and gonadal axes in children with Bardet-Biedl syndrome. Metabolism 1996, 45(10):1230-1234 (Pubitemid 26337668)
32. Cuneo Ross C: GH and Cardiac Failure. The Journal of Clinical Endocrinology & Metabolism 2001, 86(10):4635-4637
33. Biller BM: Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency. J Clin Endocrinol Metab 2002, 87:2067-2079.
34. Hoffman DM: Diagnosis of growth hormone deficiency in adults. Lancet 1994, 343:1064-1068. (Pubitemid 24128205)
35. Ghigo E: Arginine potentiates but does not restore the blunted growth hormone response to growth hormone-releasing hormone in obesity. Metabolism 1992, 41:560-563.
36. Clasey JL: Abdominal visceral fat and fasting insulin are important predictors of 24-hour GH release independent of age, gender, and other physiological factors. J Clinical Endocrinol Metab 2001, 86:3845-3852.
37. Iranmanesh A: Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men. J Clin Endocrinol Metab 1991, 73:1081-1088.
38. Veldhuis JD: Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man. J Clin Endocrinol Metab 1991, 72:51-59.
39. Tai TS, Lin SY, Sheu WH: Metabolic Effects of Growth Hormone Therapy in an Alström Syndrome Patient. Horm Res 2003, 60:297-301. (Pubitemid 37499949)
40. Maffei P, Boschetti M, Marshall JD, Paisey RB, Beck S, Resmini E, Collin GB, Naggert JK, Milan G, Vettor R, Minuto F, Sicolo N, Barreca A: Characterization of the IGF system in 15 patients with Alström syndrome. Clin Endocrinol 2007, 66(2):269-275 (Pubitemid 46096148)
41. McElhinney Doff B, Colan Steven D, Moran Adrian M, David Wypij, Ming Lin, Majzoub Joseph A, Crawford Elizabeth C, Bartlett Jodi M, McGrath Ellen A, Newburger Jane W: Recombinant Human Growth Hormone Treatment for Dilated Cardiomyopathy in Children. Pediatrics 2004, 114:e452-e458. (Pubitemid 41529742)